Table:
begin	end	state
1	16	cytoplasmic
17	35	transmembrane
36	39	non-cytoplasmic
40	60	transmembrane
61	93	cytoplasmic
94	119	transmembrane
120	124	non-cytoplasmic
125	146	transmembrane
147	153	cytoplasmic
154	177	transmembrane
178	196	non-cytoplasmic
197	219	transmembrane
220	239	cytoplasmic
240	260	transmembrane
261	273	non-cytoplasmic
274	299	transmembrane
300	330	cytoplasmic
331	353	transmembrane
354	358	non-cytoplasmic
359	380	transmembrane
381	400	cytoplasmic
401	423	transmembrane
424	428	non-cytoplasmic
429	448	transmembrane
449	461	cytoplasmic

Input:
>1937132
MADNKPELQRGLEARHIELIALGGTIGVGLFMGAASTLKWAGPSVLLAYIIAGLFVFFIM
RSMGEMLFLEPVTGSFAVYAHRYMSPFFGYLTAWSYWFMWMAVGISEITAIGVYVQFWFP
EMAQWIPALIAVALVALANLAAVRLYGEIEFWFAMIKVTTIIVMIVIGLGVIFFGFGNGG
QSIGFSNLTEHGGFFAGGWKGFLTALCIVVASYQGVELIGITAGEAKNPQVTLRSAVGKV
LWRILIFYVGAIFVIVTIFPWNEIGSNGSPFVLTFAKIGITAAAGIINFVVLTAALSGCN
SGMYSCGRMLYALAKNRQLPAAMAKVSRHGVPVAGVAVSIAILLIGSCLNYIIPNPQRVF
VYVYSASVLPGMVPWFVILISQLRFRRAHKAAIASHPFRSILFPWANYVTMAFLICVLIG
MYFNEDTRMSLFVGIIFMLAVTAIYKVFGLNRHGKAHKLEE

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server